ID   GPC6_HUMAN              Reviewed;         555 AA.
AC   Q9Y625; A8K279; Q96SG5; Q96SG8; Q9H1P4;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   28-JUN-2023, entry version 174.
DE   RecName: Full=Glypican-6;
DE   Contains:
DE     RecName: Full=Secreted glypican-6;
DE   Flags: Precursor;
GN   Name=GPC6; ORFNames=UNQ369/PRO705;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10329016; DOI=10.1006/geno.1999.5793;
RA   Paine-Saunders S., Viviano B.L., Saunders S.;
RT   "GPC6, a novel member of the glypican gene family, encodes a product
RT   structurally related to GPC4 and is colocalized with GPC5 on human
RT   chromosome 13.";
RL   Genomics 57:455-458(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   PubMed=10480909; DOI=10.1074/jbc.274.38.26968;
RA   Veugelers M., De Cat B., Ceulemans H., Bruystens A.-M., Coomans C.,
RA   Duerr J., Vermeesch J., Marynen P., David G.;
RT   "Glypican-6, a new member of the glypican family of cell surface heparan
RT   sulfate proteoglycans.";
RL   J. Biol. Chem. 274:26968-26977(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT MET-412.
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,
RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,
RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,
RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,
RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,
RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,
RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,
RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,
RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,
RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,
RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,
RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,
RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,
RA   Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INVOLVEMENT IN OMOD1.
RX   PubMed=19481194; DOI=10.1016/j.ajhg.2009.05.002;
RA   Campos-Xavier A.B., Martinet D., Bateman J., Belluoccio D., Rowley L.,
RA   Tan T.Y., Baxova A., Gustavson K.H., Borochowitz Z.U., Innes A.M.,
RA   Unger S., Beckmann J.S., Mittaz L., Ballhausen D., Superti-Furga A.,
RA   Savarirayan R., Bonafe L.;
RT   "Mutations in the heparan-sulfate proteoglycan glypican 6 (GPC6) impair
RT   endochondral ossification and cause recessive omodysplasia.";
RL   Am. J. Hum. Genet. 84:760-770(2009).
RN   [8]
RP   FUNCTION, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=21871017; DOI=10.1042/bj20110530;
RA   Yiu G.K., Kaunisto A., Chin Y.R., Toker A.;
RT   "NFAT promotes carcinoma invasive migration through glypican-6.";
RL   Biochem. J. 440:157-166(2011).
CC   -!- FUNCTION: Cell surface proteoglycan that bears heparan sulfate.
CC       Putative cell surface coreceptor for growth factors, extracellular
CC       matrix proteins, proteases and anti-proteases (By similarity). Enhances
CC       migration and invasion of cancer cells through WNT5A signaling.
CC       {ECO:0000250, ECO:0000269|PubMed:21871017}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Lipid-anchor, GPI-
CC       anchor {ECO:0000250}; Extracellular side {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Secreted glypican-6]: Secreted, extracellular
CC       space {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Widely expressed. High expression in fetal kidney
CC       and lung and lower expressions in fetal liver and brain. In adult
CC       tissues, very abundant in ovary, high levels also observed in liver,
CC       kidney, small intestine and colon. Not detected in peripheral blood
CC       leukocytes. Detected in breast cancer cells (at protein level).
CC       {ECO:0000269|PubMed:10480909, ECO:0000269|PubMed:21871017}.
CC   -!- INDUCTION: Expression is induced by NFATC2.
CC       {ECO:0000269|PubMed:21871017}.
CC   -!- DISEASE: Omodysplasia 1 (OMOD1) [MIM:258315]: A rare autosomal
CC       recessive skeletal dysplasia characterized by facial dysmorphism and
CC       severe congenital micromelia with shortening and distal tapering of the
CC       humeri and femora, to give a club-like appearance. Typical facial
CC       features include a prominent forehead, frontal bossing, short nose with
CC       a depressed broad bridge, short columella, anteverted nostrils, long
CC       philtrum, and small chin. {ECO:0000269|PubMed:19481194}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry. Point mutations leading to protein truncation, as well as larger
CC       genomic rearrangements resulting in exon deletions, have been found in
CC       family segregating omodysplasia type 1. All mutations identified in
CC       individuals affected by omodysplasia could lead to the absence of a
CC       functional protein, the mutant RNAs being suspected to be nonsense-
CC       mediated mRNA decay (NMD) targets. Even if the mRNA escapes NMD and is
CC       translated, all mutations are expected to disrupt the three-dimensional
CC       protein structure and often to abolish multiple highly conserved
CC       cysteine residues.
CC   -!- SIMILARITY: Belongs to the glypican family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF111178; AAD31392.1; -; mRNA.
DR   EMBL; AF105267; AAD55749.1; -; mRNA.
DR   EMBL; AY358462; AAQ88827.1; -; mRNA.
DR   EMBL; BC106947; AAI06948.1; -; mRNA.
DR   EMBL; AK290144; BAF82833.1; -; mRNA.
DR   EMBL; AL139798; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL160036; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL161426; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL162455; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL354811; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL137144; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS9469.1; -.
DR   RefSeq; NP_005699.1; NM_005708.4.
DR   AlphaFoldDB; Q9Y625; -.
DR   SMR; Q9Y625; -.
DR   BioGRID; 115391; 32.
DR   IntAct; Q9Y625; 16.
DR   STRING; 9606.ENSP00000366246; -.
DR   GlyGen; Q9Y625; 2 sites, 1 O-linked glycan (2 sites).
DR   iPTMnet; Q9Y625; -.
DR   PhosphoSitePlus; Q9Y625; -.
DR   BioMuta; GPC6; -.
DR   DMDM; 9973298; -.
DR   EPD; Q9Y625; -.
DR   jPOST; Q9Y625; -.
DR   MassIVE; Q9Y625; -.
DR   MaxQB; Q9Y625; -.
DR   PaxDb; Q9Y625; -.
DR   PeptideAtlas; Q9Y625; -.
DR   ProteomicsDB; 86591; -.
DR   Antibodypedia; 2876; 225 antibodies from 24 providers.
DR   CPTC; Q9Y625; 1 antibody.
DR   DNASU; 10082; -.
DR   Ensembl; ENST00000377047.9; ENSP00000366246.3; ENSG00000183098.11.
DR   GeneID; 10082; -.
DR   KEGG; hsa:10082; -.
DR   MANE-Select; ENST00000377047.9; ENSP00000366246.3; NM_005708.5; NP_005699.1.
DR   UCSC; uc001vlt.4; human.
DR   AGR; HGNC:4454; -.
DR   CTD; 10082; -.
DR   DisGeNET; 10082; -.
DR   GeneCards; GPC6; -.
DR   HGNC; HGNC:4454; GPC6.
DR   HPA; ENSG00000183098; Low tissue specificity.
DR   MalaCards; GPC6; -.
DR   MIM; 258315; phenotype.
DR   MIM; 604404; gene.
DR   neXtProt; NX_Q9Y625; -.
DR   OpenTargets; ENSG00000183098; -.
DR   Orphanet; 93329; Autosomal recessive omodysplasia.
DR   PharmGKB; PA28835; -.
DR   VEuPathDB; HostDB:ENSG00000183098; -.
DR   eggNOG; KOG3821; Eukaryota.
DR   GeneTree; ENSGT01050000244897; -.
DR   HOGENOM; CLU_024658_2_0_1; -.
DR   InParanoid; Q9Y625; -.
DR   OMA; XDESSGS; -.
DR   OrthoDB; 2939408at2759; -.
DR   PhylomeDB; Q9Y625; -.
DR   TreeFam; TF105317; -.
DR   PathwayCommons; Q9Y625; -.
DR   Reactome; R-HSA-1971475; A tetrasaccharide linker sequence is required for GAG synthesis.
DR   Reactome; R-HSA-2022928; HS-GAG biosynthesis.
DR   Reactome; R-HSA-2024096; HS-GAG degradation.
DR   Reactome; R-HSA-3560783; Defective B4GALT7 causes EDS, progeroid type.
DR   Reactome; R-HSA-3560801; Defective B3GAT3 causes JDSSDHD.
DR   Reactome; R-HSA-3656237; Defective EXT2 causes exostoses 2.
DR   Reactome; R-HSA-3656253; Defective EXT1 causes exostoses 1, TRPS2 and CHDS.
DR   Reactome; R-HSA-4420332; Defective B3GALT6 causes EDSP2 and SEMDJL1.
DR   Reactome; R-HSA-9694614; Attachment and Entry.
DR   Reactome; R-HSA-975634; Retinoid metabolism and transport.
DR   SignaLink; Q9Y625; -.
DR   SIGNOR; Q9Y625; -.
DR   BioGRID-ORCS; 10082; 9 hits in 1146 CRISPR screens.
DR   ChiTaRS; GPC6; human.
DR   GeneWiki; Glypican_6; -.
DR   GenomeRNAi; 10082; -.
DR   Pharos; Q9Y625; Tbio.
DR   PRO; PR:Q9Y625; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   RNAct; Q9Y625; protein.
DR   Bgee; ENSG00000183098; Expressed in cartilage tissue and 166 other tissues.
DR   ExpressionAtlas; Q9Y625; baseline and differential.
DR   Genevisible; Q9Y625; HS.
DR   GO; GO:0009986; C:cell surface; IBA:GO_Central.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0005615; C:extracellular space; IEA:UniProtKB-SubCell.
DR   GO; GO:0005796; C:Golgi lumen; TAS:Reactome.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045202; C:synapse; IBA:GO_Central.
DR   GO; GO:1904929; F:coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0016477; P:cell migration; IDA:UniProtKB.
DR   GO; GO:0098696; P:regulation of neurotransmitter receptor localization to postsynaptic specialization membrane; IBA:GO_Central.
DR   GO; GO:0009966; P:regulation of signal transduction; IEA:InterPro.
DR   InterPro; IPR001863; Glypican.
DR   InterPro; IPR019803; Glypican_CS.
DR   PANTHER; PTHR10822; GLYPICAN; 1.
DR   PANTHER; PTHR10822:SF31; GLYPICAN-6; 1.
DR   Pfam; PF01153; Glypican; 1.
DR   PROSITE; PS01207; GLYPICAN; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Dwarfism; Glycoprotein; GPI-anchor; Heparan sulfate;
KW   Lipoprotein; Membrane; Proteoglycan; Reference proteome; Secreted; Signal.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000255"
FT   CHAIN           24..529
FT                   /note="Glypican-6"
FT                   /id="PRO_0000012323"
FT   CHAIN           24..?
FT                   /note="Secreted glypican-6"
FT                   /id="PRO_0000333851"
FT   PROPEP          530..555
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000012324"
FT   REGION          348..376
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          480..501
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        480..499
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   LIPID           529
FT                   /note="GPI-anchor amidated serine"
FT                   /evidence="ECO:0000255"
FT   VARIANT         412
FT                   /note="V -> M (in dbSNP:rs1535692)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_024229"
FT   CONFLICT        15
FT                   /note="L -> P (in Ref. 4; BAF82833)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   555 AA;  62736 MW;  D3D01480FF9C4152 CRC64;
     MPSWIGAVIL PLLGLLLSLP AGADVKARSC GEVRQAYGAK GFSLADIPYQ EIAGEHLRIC
     PQEYTCCTTE MEDKLSQQSK LEFENLVEET SHFVRTTFVS RHKKFDEFFR ELLENAEKSL
     NDMFVRTYGM LYMQNSEVFQ DLFTELKRYY TGGNVNLEEM LNDFWARLLE RMFQLINPQY
     HFSEDYLECV SKYTDQLKPF GDVPRKLKIQ VTRAFIAART FVQGLTVGRE VANRVSKVSP
     TPGCIRALMK MLYCPYCRGL PTVRPCNNYC LNVMKGCLAN QADLDTEWNL FIDAMLLVAE
     RLEGPFNIES VMDPIDVKIS EAIMNMQENS MQVSAKVFQG CGQPKPAPAL RSARSAPENF
     NTRFRPYNPE ERPTTAAGTS LDRLVTDIKE KLKLSKKVWS ALPYTICKDE SVTAGTSNEE
     ECWNGHSKAR YLPEIMNDGL TNQINNPEVD VDITRPDTFI RQQIMALRVM TNKLKNAYNG
     NDVNFQDTSD ESSGSGSGSG CMDDVCPTEF EFVTTEAPAV DPDRREVDSS AAQRGHSLLS
     WSLTCIVLAL QRLCR
//
